
The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.
The best Bull and Bear pitches based on recency and number of recommendations.
Wow, I can't resist the chance to load up after a sell off like this one. Shares will recover with time.
dubious company with even more dubious statistics. High probability of it being a long term loser.
Read the most recent pitches from players about PRAN.
Recs
dubious company with even more dubious statistics. High probability of it being a long term loser.
Recs
Wow, I can't resist the chance to load up after a sell off like this one. Shares will recover with time.
Recs
If their new drug gets through to market it will be the next PCYC
Find the members with the highest scoring picks in PRAN.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
eruiz285 | 45.90 | 3/23/2011 |
![]() |
NS | $3.46 | -41.92% | +189.43% | +231.36 | 0 Comment | |
KidJones | 57.52 | 9/20/2012 |
![]() |
5Y | $2.55 | -21.02% | +156.32% | +177.34 | 0 Comment | |
Slyfox666 | < 20 | 12/11/2013 |
![]() |
3Y | $6.37 | -68.45% | +108.61% | +177.05 | 1 Comment | |
rwpaules | 75.00 | 9/25/2012 |
![]() |
1Y | $2.33 | -13.73% | +156.52% | +170.25 | 0 Comment | |
fatmoneyrz | 96.64 | 10/30/2013 |
![]() |
5Y | $4.75 | -57.68% | +111.83% | +169.51 | 0 Comment | |
eldeal | < 20 | 5/4/2012 |
![]() |
3W | $1.53 | +31.37% | +170.30% | +138.93 | 0 Comment | |
SimonSaysSell | 97.87 | 5/29/2014 |
![]() |
NS | $2.00 | +0.50% | +95.19% | +94.69 | 0 Comment | |
asilverp | < 20 | 8/28/2014 |
![]() |
5Y | $2.10 | -4.29% | +87.06% | +91.35 | 1 Comment | |
![]() |
CommodityBuyer | < 20 | 7/7/2015 |
![]() |
5Y | $1.15 | +75.55% | +80.91% | -5.36 | 0 Comment |
stainsolution | 73.87 | 1/12/2015 |
![]() |
5Y | $1.54 | +30.52% | +84.86% | -54.34 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.